Mets Face Roster Decision on Brazoban and Myers

Early bullpen choice between two pitchers with final minor league options could have long-term consequences

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

The New York Mets face an early roster decision this spring between relievers Huascar Brazoban and Tobias Myers, both of whom have minor league options remaining. The choice of which pitcher to send down could have lasting implications, as neither Brazoban nor Myers can be shuttled between the majors and minors indefinitely without passing through waivers.

Why it matters

The Mets will need to carefully weigh the short-term and long-term value of each pitcher. Brazoban, 36, has more big-league experience but less team control, while the younger Myers, 27, offers more long-term upside if he can establish himself in the rotation or bullpen. Burning the final option on the wrong player could make it difficult to justify keeping them on the major-league roster in the future.

The details

Brazoban and Myers are both viewed as likely to make the Mets' Opening Day roster, but the team may only have room for one of them in the bullpen. With the Mets potentially lengthening Myers out as a starter this spring, he could become an injury replacement option in the rotation, reducing the need for Brazoban as a multi-inning reliever. However, both pitchers have options remaining, meaning the Mets can freely shuttle them between the majors and minors - but only for a limited time.

  • The Mets will need to make a decision on Brazoban or Myers before the start of the 2027 season.
  • Each player can be optioned to the minors up to 5 times before needing to pass through waivers, but only has 20 days left on their final option.

The players

Huascar Brazoban

A 36-year-old reliever who found success late in his MLB career, providing the Mets with a valuable multi-inning option out of the bullpen.

Tobias Myers

A 27-year-old pitcher who made his MLB debut with the Milwaukee Brewers in 2024 and is viewed as a potential rotation or bullpen option for the Mets, with more long-term upside than Brazoban.

Got photos? Submit your photos here. ›

What’s next

The Mets will need to decide whether to option Brazoban or Myers to the minors at some point during the 2027 season, likely based on performance and roster needs.

The takeaway

This early roster decision between Brazoban and Myers highlights the careful balancing act teams must perform when managing players with limited minor league options. The Mets will need to weigh short-term bullpen needs against the long-term value of each pitcher in order to make the best choice for the franchise.